Fmr LLC 4 D Molecular Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 62,066 shares of FDMT stock, worth $589,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,066

Previous 7,866 689.04%

Holding current value

$589,006

Previous $25,000 820.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.51 - $4.79 $136,042 - $259,618	54,200 Added 689.04%	62,066 $230,000
Q1 2025 May 12, 2025	BUY	$3.23 - $6.6 $18,811 - $38,438	5,824 Added 285.21%	7,866 $25,000
Q4 2024 Feb 13, 2025	SELL	$5.3 - $10.41 $10,907 - $21,423	-2,058 Reduced 50.2%	2,042 $11,000
Q3 2024 Nov 13, 2024	SELL	$10.81 - $27.22 $10.9 Million - $27.5 Million	-1,012,123 Reduced 99.6%	4,100 $44,000
Q2 2024 Aug 13, 2024	BUY	$20.93 - $30.01 $990,847 - $1.42 Million	47,341 Added 4.89%	1,016,223 $21.3 Million
Q1 2024 May 13, 2024	BUY	$17.03 - $35.87 $16.4 Million - $34.6 Million	965,245 Added 26539.59%	968,882 $30.9 Million
Q4 2023 Feb 13, 2024	BUY	$9.76 - $21.25 $8,598 - $18,721	881 Added 31.97%	3,637 $73,000
Q3 2023 Nov 13, 2023	SELL	$12.64 - $19.76 $960 - $1,501	-76 Reduced 2.68%	2,756 $35,000
Q2 2023 Aug 11, 2023	BUY	$15.16 - $23.26 $2,092 - $3,209	138 Added 5.12%	2,832 $51,000
Q1 2023 May 11, 2023	SELL	$15.45 - $23.19 $374,013 - $561,383	-24,208 Reduced 89.99%	2,694 $46,000
Q4 2022 Feb 13, 2023	SELL	$6.85 - $25.46 $1.79 Million - $6.65 Million	-261,302 Reduced 90.67%	26,902 $597,000
Q3 2022 Nov 10, 2022	SELL	$6.96 - $11.48 $2.87 Million - $4.73 Million	-412,248 Reduced 58.85%	288,204 $2.32 Million
Q2 2022 Aug 12, 2022	SELL	$5.68 - $15.99 $2.22 Million - $6.25 Million	-390,766 Reduced 35.81%	700,452 $4.89 Million
Q1 2022 May 13, 2022	SELL	$13.16 - $22.64 $644,274 - $1.11 Million	-48,957 Reduced 4.29%	1,091,218 $16.5 Million
Q4 2021 Feb 14, 2022	BUY	$19.56 - $32.94 $2.31 Million - $3.89 Million	118,202 Added 11.57%	1,140,175 $25 Million
Q3 2021 Nov 15, 2021	SELL	$22.73 - $36.04 $358,065 - $567,738	-15,753 Reduced 1.52%	1,021,973 $27.6 Million
Q2 2021 Aug 13, 2021	BUY	$22.2 - $42.29 $23 Million - $43.9 Million	1,037,726 New	1,037,726 $25 Million

Others Institutions Holding FDMT

# of Institutions

122

Shares Held

41.2M

Call Options Held

19K

Put Options Held

38.3K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $307M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account